“6-Month Checkup”的搜索结果，显示 371-380 项，共有 14410 项

1. 外科 - 临床试验- 妙佑医疗国际

   Go to page 66 · NextNext Page. 以下为当前的临床试验。 121 研究外科（仅限仍在招募的研究）. 按院区、状态和其他条件筛选该研究列表。 A Study of the Drugs ...

2. 血液科- 临床试验- 妙佑医疗国际

   Ascorbic acid may make cancer cells more sensitive to chemotherapy. Drugs used in chemotherapy, work in different ways to stop the growth of cancer cells, ...

3. 神经外科- 临床试验- 妙佑医疗国际

   ... 6 donors per phenotype: triple negative [HER2, estrogen and ... Go to page 66 · 申请预约 · 专长与排名研究. April 18, 2026. 妙佑医疗国际明尼苏达州 ...

4. 心血管医学- 临床试验- 妙佑医疗国际

   ... exam time. A Study to Evaluate ... 6 months after the event, and (2) improves stroke outcomes at 3 months in patients who experienced an ischemic stroke.

5. 神经科- 临床试验- 妙佑医疗国际

   The Parkinson Progression Marker Initiative (PPMI) is a study to assess progression of clinical features, digital outcomes, and imaging, biologic and ...

6. 临床试验- 妙佑医疗国际儿童中心

   Rochester, Minn. The purpose of this study is to evaluate the effectiveness, safety, tolerability, and PK of INCB000928 over a 24-week treatment period followed ...

7. 神经外科- 临床试验- 妙佑医疗国际

   ... 6 donors per phenotype: triple negative [HER2, estrogen and ... Go to page 66 · 申请预约 · 专长与排名研究. April 18, 2026. 妙佑医疗国际明尼苏达州 ...

8. 血液科- 临床试验- 妙佑医疗国际

   ... 6 donors per phenotype: triple negative [HER2, estrogen and progesterone ... Go to page 66 · Go to page 77 · NextNext Page · 申请预约 · 专长与排名研究. Aug. 30 ...

9. 神经科- 临床试验- 妙佑医疗国际

   ... 6 months after the event, and (2) improves stroke outcomes at 3 months in patients who experienced an ischemic stroke. A Prospective Registry for Patients ...

10. 血液科- 临床试验- 妙佑医疗国际

    This partially randomized phase III trial studies the side effects of inotuzumab ozogamicin and how well it works when given with frontline chemotherapy in ...